JPRN-UMIN000013384已完成未知
Effect of Pitavastatin on high density lipoprotein cholesterol levels in hyperlipidemia. - Effect of Pitavastatin on high density lipoprotein cholesterol levels in hyperlipidemia.
Kanazawa Medical University Diabetology and Endocrinology0 个研究点目标入组 50 人开始时间: 2014年3月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients corresponding to the contraindication of pitavastatin 1)Known hypersensitivity to product components 2)Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels(Severe liver damage: AST, ALT >=500IU/L) 3)Co-administration with cyclosporine. 4)Pregnant women, patients who may become pregnant, or nursing mothers 2.Patients who wish to become pregnant 3.Patients who are considerd unsuitable for inclusion by the attending physician.
研究者
相似试验
已完成
4 期
The effect of pitavastatin on the lipoprotein subfraction profile and lipid metabolismJPRN-jRCT1091220056Tokyo Medical and Dental University100
已完成
不适用
Effect of pitavastatin on increasing of high-density lipoprotein cholesterol and regression of carotid artery plaque.hypercholesterolemiaJPRN-UMIN000002794Ogaki Municipal Hospital300
已完成
不适用
Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary SyndromeAcute coronary syndromeJPRN-UMIN000002742Department of Cardiology, Tokyo Women's Medical University3,000
招募中
不适用
Study of high-dose Pitavastatin on lipid and glucose metabolism disorder in Coronary Artery Disease. (Shield-CAD)Patients with stable coronary artery diseaseJPRN-UMIN000008627Minami-Osaka Hospital100
已完成
不适用
Effects of pitavastatin treatments on the plasma Lgi3 level in the patients with dyslipidemia: A randomized crossover trialKCT0003372Yonsei University Health System, Severance Hospital49